RIELLE COLEMAN: Open Payments
NPI 1902474950 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 44 payments from 15 companies in 2025. Trend: 2023 $1,038 · 2024 $2,396 · 2025 $1,289
Food & beverage: $1,289
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $319 |
| Vanda Pharmaceuticals Inc. | 5 | $199 |
| Otsuka America Pharmaceutical, Inc. | 8 | $166 |
| Teva Pharmaceuticals USA, Inc. | 3 | $138 |
| Neurocrine BioSciences, Inc. | 5 | $120 |
| Almatica Pharma LLC | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Alkermes, Inc. | 2 | $44 |
| Lundbeck LLC | 1 | $27 |
Products named: Auvelity, REXULTI, UZEDY, FANAPT, INGREZZA, HETLIOZ, LOREEV XR, CAPLYTA.
Industry payments across SC — which companies pay providers there.
